FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387190675> ?p ?o ?g. }

• W4387190675 endingPage "e070864" @default.
• W4387190675 startingPage "e070864" @default.
• W4387190675 abstract "Introduction Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating acute exacerbations of COPD (AECOPD). However, these effects have been reported with low or very low certainty evidence. This trial aims to evaluate the effectiveness and safety of SFJD for AECOPD. Methods and analysis This study is designed as a multicentre, randomised, double-blind, placebo-controlled trial. Three hundred patients with moderate or severe hospitalised AECOPD will be recruited in Beijing, Shanghai and Hefei. Participants will be randomly assigned to SFJD and usual care or placebo and usual care at a ratio of 1:1. SFJD and placebo will be administered orally four capsules three times daily for 7 consecutive days followed by an 8-week follow-up period. The primary outcome will be COPD symptom severity as measured by the EXAcerbation of Chronic Pulmonary Disease Tool score. Secondary outcomes include clinical symptoms, quality of life, length of hospital stay, a total dose of antibiotics, the frequency of recurrence of AECOPD, haematological biomarkers, death and adverse events. This study will answer the question of whether SFJD was safe to use and will improve symptoms in people with AECOPD, and will therefore reduce the necessity for antibiotics, the risk and duration of admission to hospital, and the risk of recurrence. Ethics and dissemination The ethics committee of the first affiliated hospital of Anhui Medical University, Beijing University of Chinese Medicine affiliated Dongzhimen hospital and fifth people’s hospital of Shanghai Fudan University approved the study protocol. Informed written consent will be obtained from all the participants. The results of this trial will be disseminated at academic conferences and in peer-reviewed publications. Trial registration number ISRCTN99049821 ." @default.
• W4387190675 created "2023-09-30" @default.
• W4387190675 creator A5000238995 @default.
• W4387190675 creator A5004270555 @default.
• W4387190675 creator A5011449104 @default.
• W4387190675 creator A5017300260 @default.
• W4387190675 creator A5019357161 @default.
• W4387190675 creator A5034513821 @default.
• W4387190675 creator A5036741668 @default.
• W4387190675 creator A5045900984 @default.
• W4387190675 creator A5048910824 @default.
• W4387190675 creator A5053346837 @default.
• W4387190675 creator A5059126883 @default.
• W4387190675 creator A5069775500 @default.
• W4387190675 creator A5087112542 @default.
• W4387190675 date "2023-09-01" @default.
• W4387190675 modified "2023-10-06" @default.
• W4387190675 title "Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial" @default.
• W4387190675 cites W2004111306 @default.
• W4387190675 cites W2010967671 @default.
• W4387190675 cites W2082474707 @default.
• W4387190675 cites W2108881038 @default.
• W4387190675 cites W2112162293 @default.
• W4387190675 cites W2125522165 @default.
• W4387190675 cites W2138658138 @default.
• W4387190675 cites W2171811563 @default.
• W4387190675 cites W2279879987 @default.
• W4387190675 cites W2604501983 @default.
• W4387190675 cites W2743962954 @default.
• W4387190675 cites W2751330310 @default.
• W4387190675 cites W2798095897 @default.
• W4387190675 cites W2897720739 @default.
• W4387190675 cites W2920797638 @default.
• W4387190675 cites W2934797175 @default.
• W4387190675 cites W2971829726 @default.
• W4387190675 cites W2982866503 @default.
• W4387190675 cites W3027006304 @default.
• W4387190675 cites W3094152374 @default.
• W4387190675 cites W3156517516 @default.
• W4387190675 cites W3185829027 @default.
• W4387190675 doi "https://doi.org/10.1136/bmjopen-2022-070864" @default.
• W4387190675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37775286" @default.
• W4387190675 hasPublicationYear "2023" @default.
• W4387190675 type Work @default.
• W4387190675 citedByCount "0" @default.
• W4387190675 crossrefType "journal-article" @default.
• W4387190675 hasAuthorship W4387190675A5000238995 @default.
• W4387190675 hasAuthorship W4387190675A5004270555 @default.
• W4387190675 hasAuthorship W4387190675A5011449104 @default.
• W4387190675 hasAuthorship W4387190675A5017300260 @default.
• W4387190675 hasAuthorship W4387190675A5019357161 @default.
• W4387190675 hasAuthorship W4387190675A5034513821 @default.
• W4387190675 hasAuthorship W4387190675A5036741668 @default.
• W4387190675 hasAuthorship W4387190675A5045900984 @default.
• W4387190675 hasAuthorship W4387190675A5048910824 @default.
• W4387190675 hasAuthorship W4387190675A5053346837 @default.
• W4387190675 hasAuthorship W4387190675A5059126883 @default.
• W4387190675 hasAuthorship W4387190675A5069775500 @default.
• W4387190675 hasAuthorship W4387190675A5087112542 @default.
• W4387190675 hasBestOaLocation W43871906751 @default.
• W4387190675 hasConcept C126322002 @default.
• W4387190675 hasConcept C142724271 @default.
• W4387190675 hasConcept C159110408 @default.
• W4387190675 hasConcept C168563851 @default.
• W4387190675 hasConcept C177713679 @default.
• W4387190675 hasConcept C1862650 @default.
• W4387190675 hasConcept C188947578 @default.
• W4387190675 hasConcept C197934379 @default.
• W4387190675 hasConcept C204787440 @default.
• W4387190675 hasConcept C27081682 @default.
• W4387190675 hasConcept C2776780178 @default.
• W4387190675 hasConcept C2777014857 @default.
• W4387190675 hasConcept C2779951463 @default.
• W4387190675 hasConcept C2780861865 @default.
• W4387190675 hasConcept C535046627 @default.
• W4387190675 hasConcept C71924100 @default.
• W4387190675 hasConceptScore W4387190675C126322002 @default.
• W4387190675 hasConceptScore W4387190675C142724271 @default.
• W4387190675 hasConceptScore W4387190675C159110408 @default.
• W4387190675 hasConceptScore W4387190675C168563851 @default.
• W4387190675 hasConceptScore W4387190675C177713679 @default.
• W4387190675 hasConceptScore W4387190675C1862650 @default.
• W4387190675 hasConceptScore W4387190675C188947578 @default.
• W4387190675 hasConceptScore W4387190675C197934379 @default.
• W4387190675 hasConceptScore W4387190675C204787440 @default.
• W4387190675 hasConceptScore W4387190675C27081682 @default.
• W4387190675 hasConceptScore W4387190675C2776780178 @default.
• W4387190675 hasConceptScore W4387190675C2777014857 @default.
• W4387190675 hasConceptScore W4387190675C2779951463 @default.
• W4387190675 hasConceptScore W4387190675C2780861865 @default.
• W4387190675 hasConceptScore W4387190675C535046627 @default.
• W4387190675 hasConceptScore W4387190675C71924100 @default.
• W4387190675 hasIssue "9" @default.
• W4387190675 hasLocation W43871906751 @default.
• W4387190675 hasLocation W43871906752 @default.
• W4387190675 hasOpenAccess W4387190675 @default.
• W4387190675 hasPrimaryLocation W43871906751 @default.
• W4387190675 hasRelatedWork W2083971904 @default.

• next